close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

Vivalytic | MRSA/MSSA Rapid Test

Rapid differentiation between MRSA & MSSA in 53 minutes

Bacterial Differentiation to Promote Targeted Therapy

groups_2

Enhances patient care by screening for sensitive or resistant Staphylococcus strains in wards, emergency settings, and before elective surgeries.

acute

Speed matters — results in 53 minutes versus 1-3 days with culture sampling.

coronavirus

Screening reduces health risks by preventing contamination, interrupting the infection chain, and combating AMR and superbugs.

Clinical Significance

MRSA/SA is a qualitative RT-PCR test detecting and differentiating between methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant coagulase-negative Staphylococci (MRCoNS). By using one single cartridge, the Vivalytic MRSA/SA test aids in the diagnosis of MRSA infection in a speedy manner so that appropriate antibiotic treatment can be applied, and complications prevented.

Vivalytic VS Traditional Culture Methods

The Vivalytic point of care device can provide fast and accurate results, crucial when it comes to treating infectious diseases like MRSA.

Additionally, with closed-system testing the Vivalytic also offers reduced risk of contamination compared to traditional culture methods. This is because it uses closed-system testing, which minimises the chances of contamination and helps ensure the accuracy of the results.

Moreover, the Vivalytic system also offers reduced time to diagnosis at 53 minutes, which is vital for effective infection control and patient care in comparison to traditional methods which can take up to 2-3 days. With faster and more accurate results, healthcare professionals can quickly isolate and treat patients with MRSA, reducing the risk of spread and improving patient outcomes.

Features

Sample TypeSwab
Sample Volume 600 μl
Detection MethodReal-Time PCR
Time to result53 minutes
Detectable PathogensSpecific Gene Targets
Methicillin-resistant Staphylococcus aureus (MRSA)SCCmec/orfX junction, mecA/ mecC, SA422
Methicillin-sensitive Staphylococcus aureus (MSSA)

"AWARD-WINNING DESIGN DELIVERS AN UNCOMPLICATED USER EXPERIENCE"

Vivalytic Workflow

Intuitive engineering of Vivalytic ensures the analyser is user friendly. The process of patient sample to result comprises a very simple 4 step workflow.

To begin the test, the user scans or enters sample information. The cartridge code is then scanned into the embedded Vivalytic software. The user then adds sample into the dedicated cartridge slot, closes the lid and inserts the cartridge into the Vivalytic.

The touchscreen display will countdown the time remaining to test completion. Results will be displayed on the screen. Multiple Vivalytics can be wirelessly connected allowing the user to control multiple tests at one time all reporting to a master Vivalytic platform.

Get in touch to discover more

To find out more about the Vivalytic or to discuss arranging a demo, enquire now.